Literature DB >> 8323596

Harm reduction: a public health response to the AIDS epidemic among injecting drug users.

D C Des Jarlais1, S R Friedman, T P Ward.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8323596     DOI: 10.1146/annurev.pu.14.050193.002213

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


× No keyword cloud information.
  15 in total

1.  Diffusion of the D.A.R.E and syringe exchange programs.

Authors:  Don C Des Jarlais; Zili Sloboda; Samuel R Friedman; Barbara Tempalski; Courtney McKnight; Naomi Braine
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

Review 2.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 3.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

4.  "Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain.

Authors:  Emery R Eaves
Journal:  Soc Sci Med       Date:  2015-10-19       Impact factor: 4.634

5.  Public health and church-based constructions of HIV prevention: black Baptist perspective.

Authors:  Malika Roman Isler; Eugenia Eng; Susanne Maman; Adaora Adimora; Bryan Weiner
Journal:  Health Educ Res       Date:  2014-03-17

Review 6.  An overview of the effectiveness and efficiency of HIV prevention programs.

Authors:  D R Holtgrave; N L Qualls; J W Curran; R O Valdiserri; M E Guinan; W C Parra
Journal:  Public Health Rep       Date:  1995 Mar-Apr       Impact factor: 2.792

7.  Harm reduction--a framework for incorporating science into drug policy.

Authors:  D C Des Jarlais
Journal:  Am J Public Health       Date:  1995-01       Impact factor: 9.308

Review 8.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

9.  An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

Authors:  David C Perlman; Ashly E Jordan; Anneli Uuskula; Duong Thi Huong; Carmen L Masson; Bruce R Schackman; Don C Des Jarlais
Journal:  Int J Drug Policy       Date:  2015-04-27

Review 10.  Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.

Authors:  D C Des Jarlais; S R Friedman
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.